The payer side: patient outcomes and cost
Meyers Primary Care Institute
Acute Disease; *Analgesics; *Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Costs and Cost Analysis; *Cyclooxygenase Inhibitors; Humans; Insurance, Health, Reimbursement; Managed Care Programs; *Pain; Treatment Outcome
Health Services Research | Pharmacy and Pharmaceutical Sciences | Primary Care
Payers and clinicians share a commitment to successful clinical outcomes in patients with acute or chronic pain. However, there are several issues that concern payers and managed care plans, including the cost of therapy and the cost of treating side effects. This article reviews the economic implications of pain management and the need to provide care in a clinically and economically responsible way. The article also addresses the value of medications to patients, the need for more judicious use of very expensive medications, and the use of evidence-based treatment guidelines.
DOI of Published Version
Am J Ther. 2008 Nov-Dec;15 Suppl 10:S20-2; discussion S22-3. Link to article on publisher's site
American journal of therapeutics
Fish, Leslie S. and Nicholson, Bruce D., "The payer side: patient outcomes and cost" (2008). Meyers Primary Care Institute Publications and Presentations. 536.